We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Aberdeen Emerging Markets Company Oppotunities Fund, Inc. (delisted) | AMEX:ABE | AMEX | Ordinary Share |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 14.695 | 0.00 | 00:00:00 |
PHILADELPHIA, Sept. 22, 2017 /PRNewswire/ -- Aberdeen Emerging Markets Smaller Company Opportunities Fund, Inc.1 (the "Fund") (NYSE MKT: ABE2), a closed-end equity fund, announced today its performance data and portfolio composition as of August 31, 2017.
The Fund's total returns for various periods through August 31, 2017 are provided below. (All figures are based on distributions reinvested at the dividend reinvestment price and are stated net-of-fees):
Cumulative as of 08/31/17 |
Annualized as of 08/31/17 | |||||||
1 |
3 |
YTD |
1 |
3 |
5 |
10 |
Since | |
NAV |
1.0 |
4.5 |
21.9 |
11.5 |
-0.2 |
1.9 |
1.0 |
6.7 |
Market Price |
-0.9 |
3.7 |
27.1 |
14.2 |
-0.3 |
2.3 |
0.9 |
6.2 |
MSCI Emerging Markets |
2.0 |
6.6 |
22.7 |
16.7 |
1.9 |
6.2 |
2.7 |
n/a3 |
On August 31, 2017, the Fund's net assets amounted to US$150.3 million and the Fund's NAV per share was US$15.85.
As of August 31, 2017, the portfolio was invested as follows:
Portfolio Composition |
Percent of |
Industrials |
18.7 |
Consumer Staples |
18.2 |
Consumer Discretionary |
14.7 |
Materials |
10.9 |
Real Estate |
9.5 |
Information Technology |
9.4 |
Financials |
7.8 |
Health Care |
7.8 |
Energy |
1.4 |
Cash |
1.5 |
Portfolio Composition |
Geographic Exposure % |
India |
15.3 |
Brazil |
11.1 |
Indonesia |
9.0 |
Turkey |
7.6 |
South Africa |
6.2 |
Thailand |
5.8 |
Malaysia |
5.0 |
Philippines |
4.2 |
China |
3.7 |
United States |
3.7 |
Chile |
3.2 |
Mexico |
3.2 |
South Korea |
3.0 |
Hong Kong |
2.7 |
Netherlands |
2.3 |
Poland |
2.1 |
Romania |
1.9 |
Sri Lanka |
1.9 |
Taiwan |
1.8 |
Nigeria |
1.4 |
Kenya |
1.2 |
Egypt |
1.1 |
Russia |
0.9 |
United Kingdom |
0.8 |
Peru |
0.5 |
Israel |
0.3 |
Pakistan |
0.2 |
Luxembourg |
0.1 |
The Fund's ten largest equity holdings as of August 31, 2017, representing 28.2% of net assets, were:
Stock |
Percent of Net Assets |
Godrej Consumer Products |
3.5 |
Parque Arauco |
3.2 |
Grupo Aeroportuario del Centro Norte |
3.2 |
AKR Corporindo |
3.0 |
Jollibee Foods |
2.8 |
Pacific Basin Shipping |
2.7 |
Container Corp of India Ltd. |
2.5 |
Coca-Cola Icecek |
2.5 |
ACE Hardware Indonesia |
2.4 |
Ramco Cements Ltd. |
2.4 |
Important Information
Aberdeen Asset Management Inc. (the "Administrator") has prepared this report based on information sources believed to be accurate and reliable. However, the figures are unaudited and neither the Fund, the Administrator, Aberdeen Asset Managers Limited (the "Investment Adviser"), nor any other person guarantees their accuracy. Investors should seek their own professional advice and should consider the investment objectives, risks, charges and expenses before acting on this information.
The Investment Adviser and the Administrator are each a subsidiary of Aberdeen Asset Management PLC ("Aberdeen PLC"). The merger of Standard Life plc and Aberdeen PLC, announced on March 6, 2017 ("Merger"), closed on August 14, 2017. Aberdeen PLC became a direct subsidiary of Standard Life plc as a result of the Merger and the combined company changed its name to Standard Life Aberdeen plc. Shareholders of the Fund are not required to take any action as a result of the Merger. Following the Merger, the Fund's Investment Adviser and Administrator are each an indirect subsidiary of Standard Life Aberdeen plc, but otherwise did not change. The investment advisory and administration agreements for the Fund, the services provided under the agreements, and the fees charged for services did not change as a result of the Merger. The portfolio management team for the Fund did not change as a result of the Merger.
Closed-end funds are traded on the secondary market through one of the stock exchanges. The Fund's investment return and principal value will fluctuate so that an investor's shares may be worth more or less than the original cost. Shares of closed-end funds may trade above (a premium) or below (a discount) the net asset value (NAV) of the fund's portfolio. There is no assurance that the Fund will achieve its investment objective.
Total return figures with distributions reinvested at the dividend reinvestment price are stated net-of-fees and represents past performance. Past performance is not indicative of future results, current performance may be higher or lower. Holdings are subject to change and are provided for informational purposes only and should not be deemed as a recommendation to buy or sell the securities shown. Inception date June 17, 1992.
If you wish to receive this information electronically, please contact: InvestorRelations@aberdeen-asset.com |
1 The Fund changed its name, benchmark, investment objective and strategy effective March 15, 2013. Performance information for periods prior to March 15, 2013 does not reflect the current investment strategy. The MSCI Emerging Markets Small Cap Index is the Fund's benchmark. Please refer to the Fund's January 14, 2013 proxy statement at aberdeenABE.com for additional information.
2 The Fund's ticker symbol changed from ETF to ABE at market close on July 31, 2015.
3 There is no since inception figure for the MSCI EM Small Cap Index because the inception date of the Index is June 1, 2007. The inception date of the Fund is June 17, 1992.
View original content with multimedia:http://www.prnewswire.com/news-releases/aberdeen-emerging-markets-smaller-company-opportunities-fund-inc1-announces-performance-data-and-portfolio-composition-300524524.html
SOURCE Aberdeen Emerging Markets Smaller Company Opportunities Fund, Inc.
Copyright 2017 PR Newswire
1 Year Aberdeen Emerging Markets Chart |
1 Month Aberdeen Emerging Markets Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions